fate therapeutics stock chart

The all-time high Fate Therapeutics stock closing price was 11740 on January 14 2021. At Yahoo Finance you get free stock quotes up-to-date news portfolio management resources international market data social interaction and mortgage rates.

Fate Biopharma Stock Chatter

Our cellular immunotherapies are based on our novel ex vivo cell programming approach which we apply to modulate the therapeutic.

. On the top chart youll see a display of FATEs stock price and below use the Technical Analysis selection to change companion data for the chart. FATE stock chart with full price history volume trends and moving averages. Historical daily share price chart and data for Fate Therapeutics since 2022 adjusted for splits.

The Fate Therapeutics 52-week high stock price is 9743 which is 1323 above the current share price. Advanced stock charts by MarketWatch. Fate Therapeutics Inc is a clinical-stage biopharmaceutical company based in the United States.

Fate Therapeutics FATE delivered earnings and revenue surprises of -588 and 3084 respectively for the quarter ended December 2021. It is engaged in the development of programmed cellular immunotherapies for cancer and immune disorders. Our pipeline is comprised of cell-based therapies for cancer and immune disorders.

Advanced stock charts by Barrons. FATE stock quote history news and other vital information to help you with your stock trading and investing. Fate Therapeutics Inc.

Are you thinking about adding Fate Therapeutics NASDAQFATE stock to your portfolio. FATE US31189P1021 Nasdaq. It uses human induced pluripotent stem cells iPSCs generated from its proprietary iPSC product platform to create genetically.

Note that any stock splits andor dividends are included when we calculate the FATE. We are a biopharmaceutical company dedicated to the development of programmed cellular immunotherapies. Their forecasts range from 6000 to 14500.

Technical data includes volume stock value. Download historical prices view past price performance and view a customizable stock chart with technical overlays and drawing tools for FATE at MarketBeat. Volume fell on the last day by -983 thousand shares and in total 297.

Customizable interactive chart for Fate Therapeutics with latest real-time price quote charts latest news technical analysis and opinions. Interactive Fate Therapeutics Inc. View FATE historical stock data and compare to other stocks and exchanges.

The Company is focused on the development of programmed cellular immunotherapies for patients with cancer. On average they expect Fate Therapeutics share price to reach 9300 in the next twelve months. Find the latest Fate Therapeutics Inc.

Fate Therapeutics Stock Chart and Price History 3463 011 032 As of 04222022 0655 PM. Interactive Fate Therapeutics Inc. 5 hours agoCheck out our Binance Coin historical price chart and Fate Therapeutics vs Crypto pages for additional charts.

View Fate Therapeutics FATE stock price and volume charts for most recent trading day 5-day 1-month and longer monthly and yearly timeframes. The Investor Relations website contains information about Fate Therapeutics Incs business for stockholders potential investors and financial analysts. The Fate Therapeutics stock price gained 032 on the last trading day Friday 22nd Apr 2022 rising from 3452 to 3463During the day the stock fluctuated 427 from a day low at 3396 to a day high of 3541The price has fallen in 6 of the last 10 days and is down by -1248 for this period.

Is a clinical-stage biopharmaceutical company. Real time Fate Therapeutics FATE stock price quote stock graph news analysis. This suggests a possible upside of 1588 from the stocks current price.

Ad 1000 Strong Buy Stocks that Double the SP. Fate Therapeutics Inc Biotechnology Mon 18 Apr 1110 am ET Current 1 day ago 2 days ago 3 days ago 4 days ago 5 days ago 6 days ago 7 days ago 8 days ago 9 days ago 10 days ago 11 days ago 12 days ago 13 days ago 14 days ago 15 days ago 16 days ago 17 days ago 18 days ago 19 days ago 20 days ago 21 days ago 22 days ago 23 days ago 24 days. View FATE historial stock data and compare to other stocks and exchanges.

The companys cell therapy pipeline is comprised of NK- and T-cell immuno-oncology programs including off-the-shelf engineered product. 10 brokerages have issued 12-month price objectives for Fate Therapeutics shares. Fate Therapeutics FATE Reports Q4 Loss Tops Revenue Estimates Zacks - Mon Feb 28 445PM CST.

ET View Interactive FATE Charts. FATE stock chart with full price history volume trends and moving averages. Do the numbers hold clues to.

Fate Therapeutics Inc. The latest closing stock price for Fate Therapeutics as of March 29 2022 is 4194. Historical chart prices and data share FATE THERAPEUTICS INC.

Hedge Stocks Jan 9th 2020 Hedges Stock Buy Stocks